David Schlosser, CRNA Anesthesiology Medicare: Medicare Enrolled Practice Location: 310 S Roosevelt Ave, Goldendale, WA 98620 Phone: 509-773-4022 Fax: 509-773-1941 |
News Archive
Having a child diagnosed with epilepsy can be a frightening and confusing time. Now, parents share their arduous and "circuitous" journey to get referrals for pediatric epilepsy surgery once their child's disease stops responding to anti-seizure medications. The UCLA study sheds light on the difficulties parents face obtaining specialty and sub-specialty care for their children during an already stressful time.
Sepracor Inc. and Dainippon Sumitomo Pharma Co., Ltd., an Osaka, Japan-based pharmaceutical company, announced today the intent to change the Sepracor name to Sunovion Pharmaceuticals Inc. in the United States. DSP acquired Sepracor in October 2009 and the name change is planned to occur in anticipation of the one-year anniversary of the acquisition. Sepracor intends to begin officially operating as Sunovion Pharmaceuticals Inc. before the end of 2010.
Health officials in the Pacific are concerned about two new strains of tuberculosis - multi drug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) - both strains have been found to be resistant to the two most powerful drugs that have been used to treat tuberculosis (TB) for the past five decades.
Brushing, flossing and staying away from sugary treats are the standard steps most parents take to prevent cavities in their children's teeth. It's good advice - but it's not all they need to know to keep their children's teeth healthy.
› Verified 6 days ago